Sign in
Download Opera News App

royal melbourne hospital

HEALTH

Finally, Ivermectin Proves Potential Drug for COVID-19 Control

A collaborative study led by the Monash Biomedicine Discovery Institute (BDI) with the Peter Doherty Institute of Infection and Immunity (Doherty Institute), a joint venture of the University of Melbourne and Royal Melbourne Hospital, has shown that ivermectin, an anti-parasitic drug already available around the world, kills the coronavirus in cell culture within 48 hours. Ivermectin, an FDA-approved anti-parasitic previously shown to have broad-spectrum anti-viral activity in vitro, is an inhibitor of the

  2 years ago ago
Finally, Ivermectin Proves Potential Drug for COVID-19 Control

HEALTH

Coronavirus: Possible drug identified

Possible coronavirus drug identified A collaborative study led by the Monash Biomedicine Discovery Institute (BDI) with the Peter Doherty Institute of Infection and Immunity (Doherty Institute), a joint venture of the University of Melbourne and Royal Melbourne Hospital, has shown that an anti-parasitic drug already available around the world kills the virus within 48 hours. The Monash Biomedicine Discovery Institute's Dr Kylie Wagstaff, who led the study, said the scientists showed that the drug, Ivermecti

  2 years ago ago
Coronavirus: Possible drug identified

HEALTH

Australian COVID-19 drug trial commences. Can this be hope?

An Australian trial to test the effectiveness of two drugs on patients with the COVID-19 began at the Royal Melbourne Hospital on Tuesday, with plans to expand into more than 80 hospitals. Led by Associate Professor Steven Tong, a Royal Melbourne Hospital infectious diseases clinician and co-lead of clinical research at the Doherty Institute, the study will test the efficacy of lopinavir/ritonavir, which is currently used to treat HIV, and hydroxychloroquine, used to treat arthritis and prevent and treat ma

  2 years ago ago
Australian COVID-19 drug trial commences. Can this be hope?